Imaging brain activity in conscious monkeys following oral MDMA ("ecstasy")

Mathew E Brevard1, Jerrold S Meyer, Josie A Harder

  • 1Center for Comparative Neuroimaging, University of Massachusetts Medical School, Worcester, MA 01655, USA. mathew.brevard@umassmed.edu

Insights

Recreational 3,4-methylenedioxymethamphetamine (MDMA, or "ecstasy") activates specific brain regions, including those involved in serotonin and dopamine pathways. This study reveals brain areas sensitive to MDMA, potentially vulnerable to long-term use.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Toxicology

Background:

  • Recreational 3,4-methylenedioxymethamphetamine (MDMA, or "ecstasy") use presents global health concerns.
  • Clinical evidence indicates that repeated low-dose MDMA exposure can induce neurotoxicity, impacting cognitive and psychosocial functions.

Purpose of the Study:

  • To investigate the brain's sensitivity to a single, recreational oral dose of MDMA (1 mg/kg) in conscious marmoset monkeys.
  • To identify specific brain regions and functional circuits affected by MDMA administration.

Main Methods:

  • Functional magnetic resonance imaging (fMRI) was employed in conscious marmoset monkeys.
  • Monkeys received an oral dose of MDMA (1 mg/kg) to assess immediate brain responses.

Main Results:

  • MDMA activated midbrain raphe nuclei and substantia nigra (serotonin and dopamine sources), hippocampus, hypothalamus, and amygdala.
  • A coherent activation pattern was observed in the corticostriatal circuit (dorsal thalamus, sensorimotor cortex, basal ganglia).
  • Unexpectedly intense activation occurred in the visual cortex without external stimuli, while reward areas showed minimal activation.

Conclusions:

  • This study pinpoints brain areas and functional circuits responsive to a recreational MDMA dose.
  • Certain activated regions, particularly the visual cortex, may be susceptible to long-term damage from intermittent MDMA exposure.

Related Concept Videos